secwatch.observer — SEC 8-K summary
======================================

Issuer:     REGENXBIO Inc. (RGNX)
CIK:        0001590877
Form:       8-K
Filed at:   2022-03-18T23:59:59+00:00
Accession:  0001193125-22-079590
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

REGENXBIO director Daniel Abdun-Nabi will not stand for re-election at 2022 annual meeting
--------------------------------------------------------------------------------

- Daniel J. Abdun-Nabi informed REGENXBIO he will not stand for re-election at the 2022 annual meeting.
- His term expires at the 2022 annual meeting; decision not due to any disagreement with the company.
- He served nearly six years as a director; company thanked him for his service.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1590877/000119312522079590/0001193125-22-079590-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1590877/000119312522079590/d318267d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-079590

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer